{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:16:12Z","timestamp":1785766572540,"version":"3.56.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,12]]},"DOI":"10.7759\/cureus.38948","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T22:06:55Z","timestamp":1683929215000},"source":"Crossref","is-referenced-by-count":9,"title":["Long-Term Usage of Oral Glucocorticoids Leading to Adrenal Insufficiency: A Comprehensive Review of the Literature"],"prefix":"10.7759","author":[{"given":"Ana G","family":"Monge Chac\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba Amreen","family":"Syeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Ragasri","family":"Meghana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye ES","year":"2021","unstructured":"Husebye ES, Pearce SH, Krone NP, K\u00e4mpe O. Adrenal insufficiency. Lancet. 2021, 397:613-29. 10.1016\/s0140-6736(21)00136-7","journal-title":"Lancet"},{"key":"ref2","unstructured":"Adrenal insufficiency. (2023). Accessed. 2023: https:\/\/www.statpearls.com\/articlelibrary\/nursingarticle\/17241."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxab015","article-title":"Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity","volume":"26","author":"Ahmet A","year":"2021","unstructured":"Ahmet A, Rowan-Legg A, Pancer L. Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity. Paediatr Child Health. 2021, 26:242-54. 10.1093\/pch\/pxab015","journal-title":"Paediatr Child Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008727.pub4","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia","volume":"11","author":"Rensen N","year":"2017","unstructured":"Rensen N, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. Cochrane Database Syst Rev. 2017, 11:CD008727. 10.1002\/14651858.CD008727.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0608","article-title":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol","volume":"173","author":"Woods CP","year":"2015","unstructured":"Woods CP, Argese N, Chapman M, et al.. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015, 173:633-42. 10.1530\/EJE-15-0608","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13273","article-title":"Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma","volume":"290","author":"Gurnell M","year":"2021","unstructured":"Gurnell M, Heaney LG, Price D, Menzies-Gow A. Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma. J Intern Med. 2021, 290:240-56. 10.1111\/joim.13273","journal-title":"J Intern Med"},{"key":"ref7","article-title":"Adrenal insufficiency","author":"Alexandraki KI","year":"2015","unstructured":"Alexandraki KI, Sanpawithayakul K, Grossman A. Adrenal Insufficiency. MDText.com, Inc., South Dartmouth, MA; 2015. http:\/\/europepmc.org\/article\/MED\/25905309."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2010.154","article-title":"Adverse effect of phenytoin on glucocorticoid replacement in a child with adrenal insufficiency","volume":"23","author":"Kara C","year":"2010","unstructured":"Kara C, Ucakt\u00fcrk A, Aydin OF, Aydin M. Adverse effect of phenytoin on glucocorticoid replacement in a child with adrenal insufficiency. J Pediatr Endocrinol Metab. 2010, 23:963-6. 10.1515\/jpem.2010.154","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.03.012","article-title":"Central adrenal insufficiency in children and adolescents","volume":"32","author":"Patti G","year":"2018","unstructured":"Patti G, Guzzeti C, Di Iorgi N, Maria Allegri AE, Napoli F, Loche S, Maghnie M. Central adrenal insufficiency in children and adolescents. Best Pract Res Clin Endocrinol Metab. 2018, 32:425-44. 10.1016\/j.beem.2018.03.012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa TP","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM. 2000, 93:105-11. 10.1093\/qjmed\/93.2.105","journal-title":"QJM"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a068059","article-title":"Hypothalamic-pituitary-adrenocortical suppression and recovery in renal transplant patients returning to maintenance dialysis","volume":"61","author":"Rodger RS","year":"1986","unstructured":"Rodger RS, Watson MJ, Sellars L, Wilkinson R, Ward MK, Kerr DN. Hypothalamic-pituitary-adrenocortical suppression and recovery in renal transplant patients returning to maintenance dialysis. QJ Med. 1986, 61:1039-46. 10.1093\/oxfordjournals.qjmed.a068059","journal-title":"QJ Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01545","article-title":"A general introduction to glucocorticoid biology","volume":"10","author":"Timmermans S","year":"2019","unstructured":"Timmermans S, Souffriau J, Libert C. A general introduction to glucocorticoid biology. Front Immunol. 2019, 10:1545. 10.3389\/fimmu.2019.01545","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804635","article-title":"Predisposing factors for adrenal insufficiency","volume":"360","author":"Bornstein SR","year":"2009","unstructured":"Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med. 2009, 360:2328-39. 10.1056\/NEJMra0804635","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(79)91077-8","article-title":"Adrenal suppression after short-term corticosteroid therapy","volume":"1","author":"Spiegel RJ","year":"1979","unstructured":"Spiegel RJ, Vigersky RA, Oliff AI, Echelberger CK, Bruton J, Poplack DG. Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979, 1:630-3. 10.1016\/s0140-6736(79)91077-8","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000026348","article-title":"Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy: 1. General principles","volume":"5","author":"Chrousos GP","year":"1998","unstructured":"Chrousos GP, Harris AG. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy: 1. General principles. Neuroimmunomodulation. 1998, 5:277-87. 10.1159\/000026348","journal-title":"Neuroimmunomodulation"},{"key":"ref16","article-title":"Corticosteroid adverse effects","author":"Yasir M","year":"2022","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. StatPearls Publishing, Treasure Island, FL; 2022. https:\/\/www.statpearls.com\/point-of-care\/20043."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1199","article-title":"Management of endocrine disease: glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?","volume":"184","author":"Laugesen K","year":"2021","unstructured":"Laugesen K, Broersen LH, Hansen SB, Dekkers OM, S\u00f8rensen HT, Jorgensen JO. Management of endocrine disease: glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?. Eur J Endocrinol. 2021, 184:R111-22. 10.1530\/EJE-20-1199","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen LH","year":"2015","unstructured":"Broersen LH, Pereira AM, J\u00f8rgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015, 100:2171-80. 10.1210\/jc.2015-1218","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac151","article-title":"Approach to the patient with glucocorticoid-induced adrenal insufficiency","volume":"107","author":"Borresen SW","year":"2022","unstructured":"Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U. Approach to the patient with glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab. 2022, 107:2065-76. 10.1210\/clinem\/dgac151","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417736278","article-title":"An approach to minimising risk of adrenal insufficiency when discontinuing oral glucocorticoids","volume":"22","author":"Nicholas MN","year":"2018","unstructured":"Nicholas MN, Li SK, Dytoc M. An approach to minimising risk of adrenal insufficiency when discontinuing oral glucocorticoids. J Cutan Med Surg. 2018, 22:175-81. 10.1177\/1203475417736278","journal-title":"J Cutan Med Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0176","article-title":"Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency","volume":"8","author":"Guarnotta V","year":"2019","unstructured":"Guarnotta V, Di Stefano C, Santoro A, Ciresi A, Coppola A, Giordano C. Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency. Endocr Connect. 2019, 8:853-62. 10.1530\/EC-19-0176","journal-title":"Endocr Connect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04103.x","article-title":"What is the best long-term management strategy for patients with primary adrenal insufficiency?","volume":"76","author":"Quinkler M","year":"2012","unstructured":"Quinkler M, Hahner S. What is the best long-term management strategy for patients with primary adrenal insufficiency?. Clin Endocrinol (Oxf). 2012, 76:21-5. 10.1111\/j.1365-2265.2011.04103.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman RA","year":"2013","unstructured":"Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken). 2013, 65:294-8. 10.1002\/acr.21796","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/2042018818821294","article-title":"Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency","volume":"10","author":"Oprea A","year":"2019","unstructured":"Oprea A, Bonnet NC, Poll\u00e9 O, Lysy PA. Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency. Ther Adv Endocrinol Metab. 2019, 10:2042018818821294. 10.1177\/2042018818821294","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.06.006","article-title":"Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test","volume":"147","author":"Rix M","year":"2005","unstructured":"Rix M, Birkebaek NH, Rosth\u00f8j S, Clausen N. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test. J Pediatr. 2005, 147:645-50. 10.1016\/j.jpeds.2005.06.006","journal-title":"J Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)13492-7","article-title":"Adrenal insufficiency","volume":"361","author":"Arlt W","year":"2003","unstructured":"Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003, 361:1881-93. 10.1016\/s0140-6736(03)13492-7","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610173351607","article-title":"Adrenal insufficiency","volume":"335","author":"Oelkers W","year":"1996","unstructured":"Oelkers W. Adrenal insufficiency. N Engl J Med. 1996, 335:1206-12. 10.1056\/NEJM199610173351607","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos I","year":"2015","unstructured":"Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015, 3:216-26. 10.1016\/s2213-8587(14)70142-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00153","article-title":"Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England","volume":"104","author":"Mebrahtu TF","year":"2019","unstructured":"Mebrahtu TF, Morgan AW, Keeley A, Baxter PD, Stewart PM, Pujades-Rodriguez M. Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England. J Clin Endocrinol Metab. 2019, 104:3757-67. 10.1210\/jc.2019-00153","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.05.014","article-title":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself","volume":"24","author":"Dinsen S","year":"2013","unstructured":"Dinsen S, Baslund B, Klose M, Rasmussen AK, Friis-Hansen L, Hilsted L, Feldt-Rasmussen U. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med. 2013, 24:714-20. 10.1016\/j.ejim.2013.05.014","journal-title":"Eur J Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/15.7.411","article-title":"Adrenal suppression: an under-recognized complication of a common therapy","volume":"15","author":"Goldbloom E","year":"2010","unstructured":"Goldbloom E, Ahmet A. Adrenal suppression: an under-recognized complication of a common therapy. Paediatr Child Health. 2010, 15:411-2. 10.1093\/pch\/15.7.411","journal-title":"Paediatr Child Health"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1612","article-title":"Adrenal insufficiency: still a cause of morbidity and death in childhood","volume":"119","author":"Shulman DI","year":"2007","unstructured":"Shulman DI, Palmert MR, Kemp SF. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics. 2007, 119:e484-94. 10.1542\/peds.2006-1612","journal-title":"Pediatrics"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-311223","article-title":"Symptomatic adrenal suppression among children in Canada","volume":"102","author":"Goldbloom EB","year":"2017","unstructured":"Goldbloom EB, Mokashi A, Cummings EA, et al.. Symptomatic adrenal suppression among children in Canada. Arch Dis Child. 2017, 102:338-9. 10.1136\/archdischild-2016-311223","journal-title":"Arch Dis Child"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.6.457","article-title":"Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom","volume":"87","author":"Todd GR","year":"2002","unstructured":"Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002, 87:457-61. 10.1136\/adc.87.6.457","journal-title":"Arch Dis Child"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2007.00251.x","article-title":"Fatal and near-fatal encephalopathy with hyponatraemia in two siblings with fluticasone-induced adrenal suppression","volume":"96","author":"Donaldson MD","year":"2007","unstructured":"Donaldson MD, Morrison C, Lees C, McNeill E, Howatson AG, Paton JY, McWilliam R. Fatal and near-fatal encephalopathy with hyponatraemia in two siblings with fluticasone-induced adrenal suppression. Acta Paediatr. 2007, 96:769-72. 10.1111\/j.1651-2227.2007.00251.x","journal-title":"Acta Paediatr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2018.1539148","article-title":"Prolonged adrenal insufficiency after high-dose glucocorticoid in infants with leukemia","volume":"35","author":"Moritani K","year":"2018","unstructured":"Moritani K, Tauchi H, Ochi F, et al.. Prolonged adrenal insufficiency after high-dose glucocorticoid in infants with leukemia. Pediatr Hematol Oncol. 2018, 35:355-61. 10.1080\/08880018.2018.1539148","journal-title":"Pediatr Hematol Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/000313481908500920","article-title":"A case of a post-operative addisonian crisis from HPA axis suppression from inhaled corticosteroids","volume":"85","author":"Allen G","year":"2019","unstructured":"Allen G, Mitchell A, Ramirez M, Holsten S, Shah N. A case of a post-operative addisonian crisis from HPA axis suppression from inhaled corticosteroids. Am Surg. 2019, 85:483-4. 10.1177\/000313481908500920","journal-title":"Am Surg"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1324","article-title":"Characterization of patients with adrenal insufficiency and frequent adrenal crises","volume":"184","author":"Quinkler M","year":"2021","unstructured":"Quinkler M, Murray RD, Zhang P, Marelli C, Petermann R, Isidori AM, Ekman B. Characterization of patients with adrenal insufficiency and frequent adrenal crises. Eur J Endocrinol. 2021, 184:761-71. 10.1530\/EJE-20-1324","journal-title":"Eur J Endocrinol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa011","article-title":"Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach","volume":"59","author":"Borresen SW","year":"2020","unstructured":"Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach. Rheumatology (Oxford). 2020, 59:2764-73. 10.1093\/rheumatology\/keaa011","journal-title":"Rheumatology (Oxford)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2017-0117","article-title":"Glucocorticoid-induced adrenal insufficiency: a study of the incidence in hospital patients and a review of peri-operative management","volume":"24","author":"Rushworth RL","year":"2018","unstructured":"Rushworth RL, Chrisp GL, Torpy DJ. Glucocorticoid-induced adrenal insufficiency: a study of the incidence in hospital patients and a review of peri-operative management. Endocr Pract. 2018, 24:437-45. 10.4158\/EP-2017-0117","journal-title":"Endocr Pract"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/635624","article-title":"Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults","volume":"19","author":"Lougheed MD","year":"2012","unstructured":"Lougheed MD, Lemiere C, Ducharme FM, et al.. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J. 2012, 19:127-64. 10.1155\/2012\/635624","journal-title":"Can Respir J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner S","year":"2015","unstructured":"Hahner S, Spinnler C, Fassnacht M, et al.. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015, 100:407-16. 10.1210\/jc.2014-3191","journal-title":"J Clin Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_193_17","article-title":"Management of primary adrenal insufficiency: review of current clinical practice in a developed and a developing country","volume":"21","author":"Khan U","year":"2017","unstructured":"Khan U, Lakhani OJ. Management of primary adrenal insufficiency: review of current clinical practice in a developed and a developing country. Indian J Endocrinol Metab. 2017, 21:781-3. 10.4103\/ijem.IJEM_193_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0324","article-title":"Guidance for the prevention and emergency management of adult patients with adrenal insufficiency","volume":"20","author":"Simpson H","year":"2020","unstructured":"Simpson H, Tomlinson J, Wass J, Dean J, Arlt W. Guidance for the prevention and emergency management of adult patients with adrenal insufficiency. Clin Med (Lond). 2020, 20:371-8. 10.7861\/clinmed.2019-0324","journal-title":"Clin Med (Lond)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14963","article-title":"Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK","volume":"75","author":"Woodcock T","year":"2020","unstructured":"Woodcock T, Barker P, Daniel S, et al.. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020, 75:654-63. 10.1111\/anae.14963","journal-title":"Anaesthesia"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1380","article-title":"Glucocorticoid induced adrenal insufficiency","volume":"374","author":"Prete A","year":"2021","unstructured":"Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. BMJ. 2021, 374:n1380. 10.1136\/bmj.n1380","journal-title":"BMJ"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/s1081-1206(10)60400-0","article-title":"Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review","volume":"100","author":"Wlodarczyk JH","year":"2008","unstructured":"Wlodarczyk JH, Gibson PG, Caeser M. Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review. Ann Allergy Asthma Immunol. 2008, 100:23-30. 10.1016\/s1081-1206(10)60400-0","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2020\/e2022","article-title":"Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic","volume":"75","author":"Almeida MQ","year":"2020","unstructured":"Almeida MQ, Mendonca BB. Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic. Clinics (Sao Paulo). 2020, 75:e2022. 10.6061\/clinics\/2020\/e2022","journal-title":"Clinics (Sao Paulo)"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.82","article-title":"Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study","volume":"39","author":"L\u00f6fberg R","year":"1996","unstructured":"L\u00f6fberg R, Rutgeerts P, Malchow H, et al.. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut. 1996, 39:82-6. 10.1136\/gut.39.1.82","journal-title":"Gut"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.2.209","article-title":"Oral budesonide is as effective as oral prednisolone in active Crohn's disease","volume":"41","author":"Campieri M","year":"1997","unstructured":"Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. Gut. 1997, 41:209-14. 10.1136\/gut.41.2.209","journal-title":"Gut"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.031","article-title":"The contribution of oral and inhaled glucocorticoids to adrenal insufficiency in asthma","volume":"10","author":"Brennan V","year":"2022","unstructured":"Brennan V, Martin-Grace J, Greene G, et al.. The contribution of oral and inhaled glucocorticoids to adrenal insufficiency in asthma. J Allergy Clin Immunol Pract. 2022, 10:2614-23. 10.1016\/j.jaip.2022.05.031","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.052456","article-title":"Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study","volume":"61","author":"Mortimer KJ","year":"2006","unstructured":"Mortimer KJ, Tata LJ, Smith CJ, West J, Harrison TW, Tattersfield AE, Hubbard RB. Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax. 2006, 61:405-8. 10.1136\/thx.2005.052456","journal-title":"Thorax"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review","volume":"46","author":"Joseph RM","year":"2016","unstructured":"Joseph RM, Hunter AL, Ray DW, Dixon WG. Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review. Semin Arthritis Rheum. 2016, 46:133-41. 10.1016\/j.semarthrit.2016.03.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-25-3-343","article-title":"Diurnal variation in suppression of adrenal Function by glucocorticoids","volume":"25","author":"Nichols T","year":"1965","unstructured":"Nichols T, Nugent CA, Tyler FH. Diurnal variation in suppression of adrenal Function by glucocorticoids. J Clin Endocrinol Metab. 1965, 25:343-9. 10.1210\/jcem-25-3-343","journal-title":"J Clin Endocrinol Metab"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196511182732101","article-title":"Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone","volume":"273","author":"Grant SD","year":"1965","unstructured":"Grant SD, Forsham PH, DiRaimondo VC. Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. N Engl J Med. 1965, 273:1115-8. 10.1056\/NEJM196511182732101","journal-title":"N Engl J Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a067112","article-title":"Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis","volume":"36","author":"Jasani MK","year":"1967","unstructured":"Jasani MK, Boyle JA, Greig WR, Dalakos TG, Browning MC, Thompson A, Buchanan WW. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. QJ Med. 1967, 36:261-76. 10.1093\/oxfordjournals.qjmed.a067112","journal-title":"QJ Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196802222780801","article-title":"Adrenocortical responsiveness after alternate-day corticosteroid therapy","volume":"278","author":"Ackerman GL","year":"1968","unstructured":"Ackerman GL, Nolsn CM. Adrenocortical responsiveness after alternate-day corticosteroid therapy. N Engl J Med. 1968, 278:405-9. 10.1056\/NEJM196802222780801","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0533","article-title":"Adrenal reserve following treatment of Graves' orbitopathy with intravenous glucocorticoids","volume":"25","author":"Giotaki Z","year":"2015","unstructured":"Giotaki Z, Fountas A, Tsirouki T, Bargiota A, Tigas S, Tsatsoulis A. Adrenal reserve following treatment of Graves' orbitopathy with intravenous glucocorticoids. Thyroid. 2015, 25:462-3. 10.1089\/thy.2014.0533","journal-title":"Thyroid"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1136\/ard.31.5.379","article-title":"Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function","volume":"31","author":"Carter ME","year":"1972","unstructured":"Carter ME, James VH. Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function. Ann Rheum Dis. 1972, 31:379-83. 10.1136\/ard.31.5.379","journal-title":"Ann Rheum Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3629031","article-title":"Adrenal insufficiency in cystic fibrosis: a rare phenomenon?","volume":"2018","author":"Pr\u00e9ville-Ratelle S","year":"2018","unstructured":"Pr\u00e9ville-Ratelle S, Coriati A, M\u00e9nard A, Bourdeau I, Tremblay F, Berthiaume Y. Adrenal insufficiency in cystic fibrosis: a rare phenomenon?. Can Respir J. 2018, 2018:3629031. 10.1155\/2018\/3629031","journal-title":"Can Respir J"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-1022-x","article-title":"Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir","volume":"27","author":"Yombi JC","year":"2008","unstructured":"Yombi JC, Maiter D, Belkhir L, Nzeusseu A, Vandercam B. Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol. 2008, 27:S79-82. 10.1007\/s10067-008-1022-x","journal-title":"Clin Rheumatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31829b662b","article-title":"High frequency of hypothalamic-pituitary-adrenal axis dysfunction after local corticosteroid injection in HIV-infected patients on protease inhibitor therapy","volume":"63","author":"Hyle EP","year":"2013","unstructured":"Hyle EP, Wood BR, Backman ES, et al.. High frequency of hypothalamic-pituitary-adrenal axis dysfunction after local corticosteroid injection in HIV-infected patients on protease inhibitor therapy. J Acquir Immune Defic Syndr. 2013, 63:602-8. 10.1097\/QAI.0b013e31829b662b","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00579.x","article-title":"Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature","volume":"9","author":"Foisy MM","year":"2008","unstructured":"Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med. 2008, 9:389-96. 10.1111\/j.1468-1293.2008.00579.x","journal-title":"HIV Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-6-10","article-title":"Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report","volume":"6","author":"Dort K","year":"2009","unstructured":"Dort K, Padia S, Wispelwey B, Moore CC. Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report. AIDS Res Ther. 2009, 6:10. 10.1186\/1742-6405-6-10","journal-title":"AIDS Res Ther"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01332-2","article-title":"Effects of STIP1 and GLCCI1 polymorphisms on the risk of childhood asthma and inhaled corticosteroid response in Chinese asthmatic children","volume":"20","author":"Huang J","year":"2020","unstructured":"Huang J, Hu X, Zheng X, Kuang J, Liu C, Wang X, Tang Y. Effects of STIP1 and GLCCI1 polymorphisms on the risk of childhood asthma and inhaled corticosteroid response in Chinese asthmatic children. BMC Pulm Med. 2020, 20:303. 10.1186\/s12890-020-01332-2","journal-title":"BMC Pulm Med"},{"key":"ref66","article-title":"Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre","volume":"38","author":"Bazs\u00f3 A","year":"2020","unstructured":"Bazs\u00f3 A, K\u00f6vesdi A, R\u00e1sonyi R, Nagy E, Po\u00f3r G, Pat\u00f3cs A, Kiss E. Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre. Clin Exp Rheumatol. 2020, 38:858-63.","journal-title":"Clin Exp Rheumatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.105056","article-title":"Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22\/23EK and BclI","volume":"99","author":"de Ruiter RD","year":"2014","unstructured":"de Ruiter RD, Gordijn MS, Gemke RJ, et al.. Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22\/23EK and BclI. Haematologica. 2014, 99:e136-7. 10.3324\/haematol.2014.105056","journal-title":"Haematologica"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2009.07.006","article-title":"Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone","volume":"35","author":"van Leeuwen N","year":"2010","unstructured":"van Leeuwen N, Kumsta R, Entringer S, de Kloet ER, Zitman FG, DeRijk RH, W\u00fcst S. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology. 2010, 35:339-49. 10.1016\/j.psyneuen.2009.07.006","journal-title":"Psychoneuroendocrinology"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05013.x","article-title":"Clinical features associated with glucocorticoid receptor polymorphisms. An overview","volume":"1179","author":"Manenschijn L","year":"2009","unstructured":"Manenschijn L, van den Akker EL, Lamberts SW, van Rossum EF. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci. 2009, 1179:179-98. 10.1111\/j.1749-6632.2009.05013.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1159\/000216192","article-title":"Single nucleotide polymorphisms related to HPA axis reactivity","volume":"16","author":"Derijk RH","year":"2009","unstructured":"Derijk RH. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation. 2009, 16:340-52. 10.1159\/000216192","journal-title":"Neuroimmunomodulation"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05195-0","article-title":"Associations of FKBP4 and FKBP5 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in systemic lupus erythematosus patients","volume":"40","author":"Lou QY","year":"2021","unstructured":"Lou QY, Li Z, Teng Y, et al.. Associations of FKBP4 and FKBP5 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in systemic lupus erythematosus patients. Clin Rheumatol. 2021, 40:167-79. 10.1007\/s10067-020-05195-0","journal-title":"Clin Rheumatol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13379","article-title":"Hypothalamic-pituitary-adrenal axis suppression in asthma: a glucocorticoid receptor polymorphism may protect","volume":"32","author":"Akurugu WA","year":"2021","unstructured":"Akurugu WA, Van Heerden CJ, Mulder N, Z\u00f6llner EW. Hypothalamic-pituitary-adrenal axis suppression in asthma: a glucocorticoid receptor polymorphism may protect. Pediatr Allergy Immunol. 2021, 32:273-9. 10.1111\/pai.13379","journal-title":"Pediatr Allergy Immunol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30058-4","article-title":"Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study","volume":"6","author":"Hawcutt DB","year":"2018","unstructured":"Hawcutt DB, Francis B, Carr DF, et al.. Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study. Lancet Respir Med. 2018, 6:442-50. 10.1016\/S2213-2600(18)30058-4","journal-title":"Lancet Respir Med"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13803","article-title":"Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess","volume":"89","author":"Hurtado MD","year":"2018","unstructured":"Hurtado MD, Cortes T, Natt N, Young WF Jr, Bancos I. Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess. Clin Endocrinol (Oxf). 2018, 89:721-33. 10.1111\/cen.13803","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0014","article-title":"Endocrine withdrawal syndromes","volume":"24","author":"Hochberg Z","year":"2003","unstructured":"Hochberg Z, Pacak K, Chrousos GP. Endocrine withdrawal syndromes. Endocr Rev. 2003, 24:523-38. 10.1210\/er.2001-0014","journal-title":"Endocr Rev"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212259","article-title":"Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: a Danish population-based self-controlled case series analysis","volume":"14","author":"Laugesen K","year":"2019","unstructured":"Laugesen K, Petersen I, S\u00f8rensen HT, J\u00f8rgensen JO. Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: a Danish population-based self-controlled case series analysis. PLoS One. 2019, 14:e0212259. 10.1371\/journal.pone.0212259","journal-title":"PLoS One"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1007-5","article-title":"Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome","volume":"55","author":"Prete A","year":"2017","unstructured":"Prete A, Paragliola RM, Bottiglieri F, Rota CA, Pontecorvi A, Salvatori R, Corsello SM. Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome. Endocrine. 2017, 55:969-80. 10.1007\/s12020-016-1007-5","journal-title":"Endocrine"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3632","article-title":"Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology","volume":"100","author":"Berr CM","year":"2015","unstructured":"Berr CM, Di Dalmazi G, Osswald A, et al.. Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology. J Clin Endocrinol Metab. 2015, 100:1300-8. 10.1210\/jc.2014-3632","journal-title":"J Clin Endocrinol Metab"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(02)00008-7","article-title":"Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review","volume":"31","author":"Richter B","year":"2002","unstructured":"Richter B, Neises G, Clar C. Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review. Endocrinol Metab Clin North Am. 2002, 31:751-78. 10.1016\/s0889-8529(02)00008-7","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.087247","article-title":"Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone","volume":"91","author":"Paton J","year":"2006","unstructured":"Paton J, Jardine E, McNeill E, Beaton S, Galloway P, Young D, Donaldson M. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch Dis Child. 2006, 91:808-13. 10.1136\/adc.2005.087247","journal-title":"Arch Dis Child"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21339","article-title":"Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia","volume":"50","author":"Einaudi S","year":"2008","unstructured":"Einaudi S, Bertorello N, Masera N, et al.. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008, 50:537-41. 10.1002\/pbc.21339","journal-title":"Pediatr Blood Cancer"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2007.20.2.219","article-title":"Inappropriate use of potent topical glucocorticoids in infants","volume":"20","author":"Ozon A","year":"2007","unstructured":"Ozon A, Cetinkaya S, Alikasifoglu A, Gonc EN, Sen Y, Kandemir N. Inappropriate use of potent topical glucocorticoids in infants. J Pediatr Endocrinol Metab. 2007, 20:219-25. 10.1515\/jpem.2007.20.2.219","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.077","article-title":"Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection","volume":"115","author":"Weiss AH","year":"2008","unstructured":"Weiss AH, Kelly JP. Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection. Ophthalmology. 2008, 115:390-7. 10.1016\/j.ophtha.2007.03.077","journal-title":"Ophthalmology"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-7-13","article-title":"Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy","volume":"7","author":"Ahmet A","year":"2011","unstructured":"Ahmet A, Kim H, Spier S. Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol. 2011, 7:13. 10.1186\/1710-1492-7-13","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23123","article-title":"Frequency and duration of adrenal suppression following glucocorticoid therapy in children with rheumatic diseases","volume":"69","author":"Ahmet A","year":"2017","unstructured":"Ahmet A, Brienza V, Tran A, et al.. Frequency and duration of adrenal suppression following glucocorticoid therapy in children with rheumatic diseases. Arthritis Care Res (Hoboken). 2017, 69:1224-30. 10.1002\/acr.23123","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)06290-x","article-title":"Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment","volume":"355","author":"Henzen C","year":"2000","unstructured":"Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet. 2000, 355:542-5. 10.1016\/s0140-6736(99)06290-x","journal-title":"Lancet"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.01.011","article-title":"A search for variables predicting cortisol response to low-dose corticotropin stimulation following supraphysiological doses of glucocorticoids","volume":"163","author":"Wildi-Runge S","year":"2013","unstructured":"Wildi-Runge S, Delado\u00eby J, B\u00e9langer C, Deal CL, Van Vliet G, Alos N, Huot C. A search for variables predicting cortisol response to low-dose corticotropin stimulation following supraphysiological doses of glucocorticoids. J Pediatr. 2013, 163:484-8. 10.1016\/j.jpeds.2013.01.011","journal-title":"J Pediatr"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(86)90315-5","article-title":"Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma","volume":"77","author":"Zora JA","year":"1986","unstructured":"Zora JA, Zimmerman D, Carey TL, O'Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol. 1986, 77:9-13. 10.1016\/0091-6749(86)90315-5","journal-title":"J Allergy Clin Immunol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12655","article-title":"Adrenal responses to a low-dose short synacthen test in children with asthma","volume":"82","author":"Hawcutt DB","year":"2015","unstructured":"Hawcutt DB, Jorgensen AL, Wallin N, et al.. Adrenal responses to a low-dose short synacthen test in children with asthma. Clin Endocrinol (Oxf). 2015, 82:648-56. 10.1111\/cen.12655","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000848","article-title":"Adrenal suppression in children treated with oral viscous budesonide for eosinophilic esophagitis","volume":"61","author":"Harel S","year":"2015","unstructured":"Harel S, Hursh BE, Chan ES, Avinashi V, Panagiotopoulos C. Adrenal suppression in children treated with oral viscous budesonide for eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2015, 61:190-3. 10.1097\/MPG.0000000000000848","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-016-0154-9","article-title":"Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis","volume":"12","author":"Ahmet A","year":"2016","unstructured":"Ahmet A, Benchimol EI, Goldbloom EB, Barkey JL. Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis. Allergy Asthma Clin Immunol. 2016, 12:49. 10.1186\/s13223-016-0154-9","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1530\/EC-16-0054","article-title":"Society for Endocrinology Endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients","volume":"5","author":"Arlt W","year":"2016","unstructured":"Arlt W. Society for Endocrinology Endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr Connect. 2016, 5:G1-3. 10.1530\/EC-16-0054","journal-title":"Endocr Connect"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa133","article-title":"Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery","volume":"105","author":"Prete A","year":"2020","unstructured":"Prete A, Taylor AE, Bancos I, et al.. Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery. J Clin Endocrinol Metab. 2020, 105:2262-74. 10.1210\/clinem\/dgaa133","journal-title":"J Clin Endocrinol Metab"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein SR","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, et al.. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016, 101:364-89. 10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0361","article-title":"Endocrinology in the time of COVID-19: management of adrenal insufficiency","volume":"183","author":"Arlt W","year":"2020","unstructured":"Arlt W, Baldeweg SE, Pearce SH, Simpson HL. Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol. 2020, 183:G25-32. 10.1530\/EJE-20-0361","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142477-long-term-usage-of-oral-glucocorticoids-leading-to-adrenal-insufficiency-a-comprehensive-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:50Z","timestamp":1707508790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142477-long-term-usage-of-oral-glucocorticoids-leading-to-adrenal-insufficiency-a-comprehensive-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":95,"URL":"https:\/\/doi.org\/10.7759\/cureus.38948","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}